-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, after review, the State Medical Products Administration approved the registration
of the innovative product "artificial blood vessels" produced by Jiangsu Baiyouda Life Science and Technology Co.
, Ltd.
of the innovative product "artificial blood vessels" produced by Jiangsu Baiyouda Life Science and Technology Co.
, Ltd.
The artificial blood vessels are mainly made of PET thread weaving and coated with bovine collagen and glycerin
.
The polyester weaving of this product adopts an innovative weaving process, the outer warp yarn is made of elastic yarn (polyester low-elastic DTY yarn), the middle layer is made of non-elastic yarn (polyester fully drafted FDY yarn), and the weft yarn is composed of elastic yarn and non-elastic yarn
.
This weaving process results in smaller and more uniform porosity in the fabric, which is expected to improve the bleeding properties
of the finished product.
Artificial blood vessels are used for replacement or bypass surgery of the aorta and its branching vessels
.
The launch of this product will provide more options
for clinical treatment.
.
The polyester weaving of this product adopts an innovative weaving process, the outer warp yarn is made of elastic yarn (polyester low-elastic DTY yarn), the middle layer is made of non-elastic yarn (polyester fully drafted FDY yarn), and the weft yarn is composed of elastic yarn and non-elastic yarn
.
This weaving process results in smaller and more uniform porosity in the fabric, which is expected to improve the bleeding properties
of the finished product.
Artificial blood vessels are used for replacement or bypass surgery of the aorta and its branching vessels
.
The launch of this product will provide more options
for clinical treatment.
The drug administration department will strengthen the post-marketing supervision of the product to protect the safety of
patients.
patients.
